Masimo | MASI - Nettoeinkommen

Aktienkurs
178.63
Täglich Wechseln
-0.08 -0.04%
Monatlich
0.30%
Jährlich
9.09%
Q2 Prognose
174.81




Nettoeinkommen Veränderung Datum
Abbott USD 1.08B 699M 2026-03
Accuray USD 2.54M 6.49M 2024-12
Align Technology USD 135.76M 79.01M 2025-12
AngioDynamics USD -6.35M 4.55M 2025-09
Artivion USD 2.42M 4.07M 2025-12
AtriCure USD 1.76M 2.02M 2025-12
Avanos Medical USD -1.3M 100K 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Boston Scientific USD 672M 83M 2025-12
Dexcom USD 267.3M 16.5M 2025-12
Edwards Lifesciences USD 380.7M 289.5M 2026-03
General Electric Aerospace USD 1.9B 637M 2026-03
Globus Medical USD 140.59M 21.63M 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 101.6M 14M 2025-12
Integra LifeSciences USD -1.7M 3.7M 2025-12
Intuitive Surgical USD 821.5M 26.7M 2026-03
Masimo USD 68.3M 168.7M 2025-12
Medtronic USD 1.14B 231M 2025-12
Orthofix International USD -2.22M 20.57M 2025-12
Owens Minor USD -56.33M 93.95M 2025-12
ResMed USD 392.59M 44.06M 2025-12
Steris USD 192.9M 1000K 2025-12
Stryker USD 849M 10M 2025-12
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -714.33M 305.44M 2025-12
Thermo Fisher Scientific USD 1.65B 313M 2026-03
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12